4-55952195-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_025009.5(CEP135):c.65G>A(p.Arg22His) variant causes a missense change. The variant allele was found at a frequency of 0.0000093 in 1,613,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R22C) has been classified as Likely benign.
Frequency
Consequence
NM_025009.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP135 | NM_025009.5 | c.65G>A | p.Arg22His | missense_variant | 2/26 | ENST00000257287.5 | |
CEP135 | XM_006714055.4 | c.65G>A | p.Arg22His | missense_variant | 2/26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP135 | ENST00000257287.5 | c.65G>A | p.Arg22His | missense_variant | 2/26 | 1 | NM_025009.5 | P1 | |
CEP135 | ENST00000422247.6 | c.65G>A | p.Arg22His | missense_variant | 2/6 | 2 | |||
CEP135 | ENST00000506809.1 | n.225G>A | non_coding_transcript_exon_variant | 2/2 | 3 | ||||
CEP135 | ENST00000706800.1 | n.238G>A | non_coding_transcript_exon_variant | 2/5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152144Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251378Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135870
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1461028Hom.: 0 Cov.: 29 AF XY: 0.00000825 AC XY: 6AN XY: 726872
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152262Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74462
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 11, 2022 | The c.65G>A (p.R22H) alteration is located in exon 2 (coding exon 1) of the CEP135 gene. This alteration results from a G to A substitution at nucleotide position 65, causing the arginine (R) at amino acid position 22 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at